Guildford, UK, 21 January 2014: ReNeuron Group plc is pleased to announce the publication in a peer-reviewed scientific journal of key pre-clinical efficacy data with its human retinal progenitor cells (hRPCs) in a model of retinal degeneration.
The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: